On 2026-03-23, Aardvark Therapeutics, Inc. (AARD) announced earnings per share of $-0.81 for the fiscal quarter ending 2025-12-31, meeting the average analyst estimate of $-0.81.
The next expected annoucement date for quarterly earnings is 2026-05-13, with an average estimated earnings per share of $-0.81 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-23 | 2025-12-31 | $-0.81 | $-0.81 |
| 2025-11-13 | 2025-09-30 | $-0.82 | $-0.75 |
| 2025-08-13 | 2025-06-30 | $-0.52 | $-0.66 |
| 2025-05-14 | 2025-03-31 | $-0.70 | $-0.71 |